About Biorasis
Biorasis is a Healthcare company based in Mansfield (United Kingdom) founded in 2007. Continuous glucose monitoring is facilitated by a sensor platform. It operates in the Healthcare and Technology sectors. Biorasis has raised $3 million across 10 funding rounds from investors including HHS, MassChallenge and Helmsley Charitable Trust. Biorasis offers products and services including GLUCOWIZZARD and Metabolic Monitoring Platform. Its focus areas include High Tech, Wearable Technology, Health and Wellness Devices and Diabetes Monitoring. Its legal entity is Biorasis, Inc.
Company details
Biorasis was founded in 2007 and is based in Mansfield, United Kingdom. Operations focus on the medical device sector, where a sensor platform for continuous glucose monitoring is developed. Glucose levels are read by a tiny sensor and transmitted to personal digital accessories like smartphones or computers. An implantable multi-sensor platform is also offered for real-time, continuous monitoring of vital signs.
- Headquarters Mansfield, United Kingdom
- SectorsHealthcareTechnology
- Website bio-orasis.com
- Legal Name Biorasis, Inc
- Total Equity Funding$3M (USD)
in 10 rounds
- Latest Funding Round$3M (USD), Series A
Nov 2018
- InvestorsHHS
& 3 more
Products & Services of Biorasis
Biorasis offers a comprehensive portfolio of products and services, including GLUCOWIZZARD and Metabolic Monitoring Platform.
Miniaturized device for reading and transmitting glucose levels wirelessly.
Platform for real-time continuous monitoring of metabolic indicators.
Funding Insights of Biorasis
Biorasis has successfully raised a total of $3M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3M
- Total Rounds 10
- Last Round Series A — $3M
- First Round $901,387
(Sep 2009)
- Investors Count 4
All 10 funding rounds of Biorasis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2018 | $3M | Series A | – | – | |
| May 2016 | $300,000 | Grant | – | – | |
| Oct 2015 | $100,000 | Grant | – | – | |
| May 2015 | $224,118 | Grant | – | – | |
| Sep 2012 | $696,404 | Grant | – | – | |
| Aug 2012 | $486,000 | Grant | – | – | – |
| Jan 2011 | $150,000 | Grant | – | – | |
| Nov 2010 | $150,000 | Grant | – | – | |
| Sep 2009 | $901,387 | Grant | – | – | |
| Sep 2009 | $901,387 | Grant | – | – |
4 investors in total: 4 institutional.
Investors in Biorasis
Biorasis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, MassChallenge and Helmsley Charitable Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage entrepreneurs are accelerated through MassChallenge's program. | masschallenge.org | Boston, United States | ||
A charitable trust focused on healthcare and research funding. | helmsleytrust.org | New York, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Biorasis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biorasis
1 people are tracked at Biorasis (1 in leadership).
| Name | Role | Group |
|---|---|---|
Ioannis Tomazos | Chief Executive Officer | Leadership |
Complete people profiles for Biorasis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biorasis
3 dated milestones of Biorasis across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Biorasis is founded.
- Funding First funding round of $901K.
- Funding Latest funding round, Series A, of $3.0M.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biorasis
Biorasis was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Biorasis is headquartered in Mansfield, United Kingdom. It is registered at Mansfield, England, United Kingdom.
Biorasis is a funded company, having raised a total of $3M across 10 funding rounds to date. The company's 1st funding round was a Grant of $901.39K, raised on Sep 2009.
Biorasis was founded in 2007 and is based in Mansfield, United Kingdom. Operations focus on the medical device sector, where a sensor platform for continuous glucose monitoring is developed. Glucose levels are read by a tiny sensor and transmitted to personal digital accessories like smartphones or computers. An implantable multi-sensor platform is also offered for real-time, continuous monitoring of vital signs.
Biorasis offers GLUCOWIZZARD and Metabolic Monitoring Platform.
Biorasis has 4 investors. Key investors include HHS, MassChallenge, Helmsley Charitable Trust, and National Science Foundation.
Biorasis operates through Biorasis, Inc.